Literature DB >> 9863786

Prospects for worldwide tuberculosis control under the WHO DOTS strategy. Directly observed short-course therapy.

C Dye1, G P Garnett, K Sleeman, B G Williams.   

Abstract

BACKGROUND: WHO advocates the use of directly observed treatment with a short-course drug regimen as part of the DOTS strategy, but the potential effect of this strategy worldwide has not been investigated.
METHODS: We developed an age-structured mathematical model to explore the characteristics of tuberculosis control under DOTS, and to forecast the effect of improved case finding and cure on tuberculosis epidemics for each of the six WHO regions.
FINDINGS: In countries where the incidence of tuberculosis is stable and HIV-1 absent, a control programme that reaches the WHO targets of 70% case detection and 85% cure would reduce the incidence rate by 11% (range 8-12) per year and the death rate by 12% (9-13) per year. If tuberculosis has been in decline for some years, the same case detection and cure rates would have a smaller effect on incidence. DOTS saves a greater proportion of deaths than cases, and this difference is bigger in the presence of HIV-1. HIV-1 epidemics cause an increase in tuberculosis incidence, but do not substantially reduce the preventable proportion of cases and deaths. Without greater effort to control tuberculosis, the annual incidence of the disease is expected to increase by 41% (21-61) between 1998 and 2020 (from 7.4 million to 10.6 million cases per year). Achievement of WHO targets by 2010 would prevent 23% (15-30) or 48 million cases by 2020.
INTERPRETATION: The potential effect of chemotherapy (delivered as DOTS) on tuberculosis is greater in many developing countries now than it was in developed countries 50 years ago. To exploit this potential, case detection and cure rates urgently need to be improved in the main endemic areas.

Entities:  

Mesh:

Year:  1998        PMID: 9863786     DOI: 10.1016/s0140-6736(98)03199-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  135 in total

1.  Criteria for the control of drug-resistant tuberculosis.

Authors:  C Dye; B G Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-05       Impact factor: 11.205

2.  Directly observed treatment for tuberculosis.

Authors:  Paul Garner; Jimmy Volmink
Journal:  BMJ       Date:  2003-10-11

3.  Gene-gene interaction between tuberculosis candidate genes in a South African population.

Authors:  Erika de Wit; Lize van der Merwe; Paul D van Helden; Eileen G Hoal
Journal:  Mamm Genome       Date:  2010-08-27       Impact factor: 2.957

4.  The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Authors:  Gwenan M Knight; Caroline Colijn; Sourya Shrestha; Mariam Fofana; Frank Cobelens; Richard G White; David W Dowdy; Ted Cohen
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

5.  Cost effectiveness analysis of strategies for tuberculosis control in developing countries.

Authors:  Rob Baltussen; Katherine Floyd; Christopher Dye
Journal:  BMJ       Date:  2005-11-10

6.  The impact of HIV/AIDS on the control of tuberculosis in India.

Authors:  B G Williams; R Granich; L S Chauhan; N S Dharmshaktu; C Dye
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-23       Impact factor: 11.205

7.  Exogenous re-infection and the dynamics of tuberculosis epidemics: local effects in a network model of transmission.

Authors:  Ted Cohen; Caroline Colijn; Bryson Finklea; Megan Murray
Journal:  J R Soc Interface       Date:  2007-06-22       Impact factor: 4.118

8.  Limited impact of tuberculosis control in Hong Kong: attributable to high risks of reactivation disease.

Authors:  E Vynnycky; M W Borgdorff; C C Leung; C M Tam; P E M Fine
Journal:  Epidemiol Infect       Date:  2007-08-03       Impact factor: 2.451

Review 9.  Revised guidelines for the diagnosis and control of tuberculosis: impact on management in the elderly.

Authors:  Paul Van den Brande
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

10.  Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum.

Authors:  D J Park; F A Drobniewski; A Meyer; S M Wilson
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.